Canadian Pediatric Research Faces Turmoil Over Fabricated Cases

A significant controversy has emerged in Canadian pediatric medicine, sparked by revelations about fabricated case studies that have compromised scientific integrity. The situation escalated following an investigative article published by *The New Yorker* on January 3, 2026, written by Pulitzer Prize-winning journalist Ben Taub. This piece delves into the contentious relationship between Gideon Koren, the founder of the discredited Motherisk lab, and his former colleague David Juurlink, a well-respected pharmacologist at Sunnybrook Hospital and the University of Toronto.

The Motherisk lab, known for its flawed drug-testing procedures, significantly impacted Ontario’s child protection system over the last decade. Koren, who retired in 2015 and lost his Ontario medical license in 2019, has been a central figure in this scandal, which has already received extensive media coverage, particularly from the *Toronto Star*.

While Taub’s article touches on the Motherisk scandal, it primarily investigates a specific incident surrounding a 2006 paper published in The Lancet. This paper, co-authored by Koren and four other doctors, including James Cairns, a former deputy chief coroner of Ontario, claims that a baby boy named Tariq Jamieson died due to an overdose of morphine transferred through breast milk after his mother ingested Tylenol-3, a medication containing acetaminophen and codeine.

The claims presented in the paper have been met with skepticism, particularly by Juurlink, who, while attending a conference in Scotland, was questioned by a colleague about the credibility of Koren’s research. The findings reported in the autopsy of Tariq suggested that the morphine levels were biologically implausible to have originated from his mother’s medication intake.

After conducting a thorough investigation, Juurlink discovered that the baby’s stomach contained significant amounts of unmetabolized codeine, indicating a direct administration rather than a transfer through breast milk. His efforts to have the paper retracted culminated in a significant acknowledgment from The Lancet, which issued an “Expression of Concern” regarding the paper on February 3, 2026.

The fallout did not stop there. A pivotal piece of evidence supporting Koren’s assertions was a case report published in Paediatrics & Child Health, the official journal of the Canadian Paediatric Society. This report, detailing a “Baby Boy Blue” case, was also co-authored by Koren and claimed a similar scenario involving a mother who breastfed after taking Tylenol-3.

In a surprising twist, when Juurlink confronted Michael Rieder, co-author of the “Baby Boy Blue” case, he was met with a shocking admission: “We made it up.” It emerged that the journal had allowed authors to create fictional case studies for educational purposes without disclosing this practice in the published reports. This admission has raised significant concerns about the integrity of medical literature, as these fabricated cases have been cited widely and mischaracterized as genuine.

The implications of such editorial policies are far-reaching. The editor of Paediatrics & Child Health has announced plans to include disclaimers on 138 reports that were previously presented as authentic. This incident highlights a troubling trend within medical publishing, where the line between factual reporting and fabricated narratives has become alarmingly blurred.

The Canadian Paediatric Society defended the practice of publishing fictional cases, citing the need to protect patient confidentiality. This justification has sparked debate about the balance between confidentiality and transparency in medical research. The broader implications of these revelations touch upon the erosion of public trust in the medical profession and the systems meant to safeguard child welfare.

As the medical community grapples with the ramifications of this scandal, the focus will likely shift towards ensuring accountability and restoring faith in the integrity of medical research. These events serve as a stark reminder of the critical need for rigorous standards in scientific publishing and the importance of transparency in research methodology.